Market Closed -
Nyse
04:00:01 2024-05-08 pm EDT
|
Pre-market
08:31:29 am
|
130.5
USD
|
-0.83%
|
|
130.8
|
+0.29%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,745
|
15,705
|
27,346
|
25,406
|
16,955
|
15,333
|
-
|
-
|
Enterprise Value (EV)
1 |
10,182
|
18,530
|
29,301
|
27,124
|
20,232
|
19,721
|
19,244
|
20,407
|
P/E ratio
|
14.5
x
|
41.9
x
|
221
x
|
9.49
x
|
10.8
x
|
44.9
x
|
9.81
x
|
10.8
x
|
Yield
|
2.01%
|
1.04%
|
0.67%
|
0.73%
|
-
|
1.23%
|
1.25%
|
1.31%
|
Capitalization / Revenue
|
2.16
x
|
5.02
x
|
8.22
x
|
3.47
x
|
1.76
x
|
2.54
x
|
2.1
x
|
1.78
x
|
EV / Revenue
|
2.84
x
|
5.92
x
|
8.8
x
|
3.71
x
|
2.1
x
|
3.27
x
|
2.64
x
|
2.37
x
|
EV / EBITDA
|
9.82
x
|
22.6
x
|
33.6
x
|
7.8
x
|
6
x
|
15.4
x
|
10.5
x
|
9.25
x
|
EV / FCF
|
-76.9
x
|
-359
x
|
-48.1
x
|
42
x
|
-24.6
x
|
-38
x
|
606
x
|
49.3
x
|
FCF Yield
|
-1.3%
|
-0.28%
|
-2.08%
|
2.38%
|
-4.07%
|
-2.63%
|
0.17%
|
2.03%
|
Price to Book
|
1.97
x
|
3.69
x
|
4.86
x
|
3.2
x
|
1.8
x
|
1.52
x
|
1.44
x
|
1.38
x
|
Nbr of stocks (in thousands)
|
106,033
|
106,457
|
116,976
|
117,153
|
117,353
|
117,527
|
-
|
-
|
Reference price
2 |
73.04
|
147.5
|
233.8
|
216.9
|
144.5
|
130.5
|
130.5
|
130.5
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,589
|
3,129
|
3,328
|
7,320
|
9,617
|
6,029
|
7,287
|
8,593
|
EBITDA
1 |
1,037
|
818.7
|
871
|
3,476
|
3,370
|
1,278
|
1,830
|
2,206
|
EBIT
1 |
823.3
|
586.8
|
617
|
3,175
|
2,940
|
680.9
|
1,300
|
1,543
|
Operating Margin
|
22.94%
|
18.75%
|
18.54%
|
43.37%
|
30.57%
|
11.29%
|
17.84%
|
17.96%
|
Earnings before Tax (EBT)
1 |
563
|
373.5
|
133.6
|
2,433
|
246.7
|
-417.9
|
1,287
|
1,926
|
Net income
1 |
533.2
|
375.8
|
123.7
|
2,690
|
1,573
|
365.1
|
1,573
|
2,909
|
Net margin
|
14.86%
|
12.01%
|
3.72%
|
36.75%
|
16.36%
|
6.06%
|
21.58%
|
33.86%
|
EPS
2 |
5.020
|
3.520
|
1.060
|
22.84
|
13.36
|
2.903
|
13.30
|
12.07
|
Free Cash Flow
1 |
-132.4
|
-51.56
|
-609.4
|
646.2
|
-824
|
-518.5
|
31.76
|
414.2
|
FCF margin
|
-3.69%
|
-1.65%
|
-18.31%
|
8.83%
|
-8.57%
|
-8.6%
|
0.44%
|
4.82%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
18.59%
|
-
|
-
|
1.74%
|
18.77%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
24.02%
|
-
|
-
|
2.02%
|
14.24%
|
Dividend per Share
2 |
1.470
|
1.540
|
1.560
|
1.580
|
-
|
1.607
|
1.632
|
1.703
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
894.2
|
1,128
|
1,480
|
2,092
|
2,621
|
2,580
|
2,370
|
2,311
|
2,356
|
1,361
|
1,374
|
1,518
|
1,732
|
1,537
|
1,612
|
EBITDA
1 |
228.7
|
431.9
|
610.2
|
1,190
|
1,244
|
1,596
|
1,032
|
453.3
|
289.1
|
291.2
|
278
|
326.4
|
393.2
|
375.5
|
407
|
EBIT
1 |
160.5
|
365.4
|
539.2
|
1,112
|
1,158
|
1,508
|
939.2
|
347.8
|
145
|
167.5
|
173.9
|
247.4
|
278.4
|
204.6
|
239.2
|
Operating Margin
|
17.95%
|
32.4%
|
36.44%
|
53.17%
|
44.19%
|
58.46%
|
39.62%
|
15.05%
|
6.15%
|
12.31%
|
12.65%
|
16.3%
|
16.08%
|
13.31%
|
14.84%
|
Earnings before Tax (EBT)
1 |
-8.062
|
299.6
|
401.5
|
869.3
|
863.1
|
1,157
|
168.4
|
-158.2
|
-921
|
-167.6
|
-48.1
|
-80.1
|
-26.05
|
-
|
-
|
Net income
1 |
-3.824
|
253.4
|
406.8
|
897.2
|
1,132
|
1,239
|
650
|
302.5
|
-617.7
|
-9.136
|
93.74
|
87.89
|
122.7
|
362
|
390
|
Net margin
|
-0.43%
|
22.47%
|
27.49%
|
42.89%
|
43.21%
|
48%
|
27.43%
|
13.09%
|
-26.22%
|
-0.67%
|
6.82%
|
5.79%
|
7.09%
|
23.56%
|
24.2%
|
EPS
2 |
-0.0300
|
2.150
|
3.460
|
7.610
|
9.600
|
10.51
|
5.520
|
2.570
|
-5.260
|
-0.0800
|
0.6833
|
0.6333
|
0.9333
|
3.080
|
3.320
|
Dividend per Share
2 |
0.3900
|
0.3950
|
0.3950
|
0.3950
|
0.3950
|
0.4000
|
0.4000
|
0.4000
|
-
|
-
|
0.4655
|
0.4689
|
0.4689
|
0.5126
|
0.5192
|
Announcement Date
|
2/16/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/15/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/14/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,437
|
2,825
|
1,955
|
1,718
|
3,277
|
4,389
|
3,911
|
5,075
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.351
x
|
3.451
x
|
2.245
x
|
0.4943
x
|
0.9723
x
|
3.434
x
|
2.138
x
|
2.3
x
|
Free Cash Flow
1 |
-132
|
-51.6
|
-609
|
646
|
-824
|
-519
|
31.8
|
414
|
ROE (net income / shareholders' equity)
|
17.1%
|
9.16%
|
8.31%
|
19%
|
30.1%
|
3.48%
|
8.7%
|
7.98%
|
ROA (Net income/ Total Assets)
|
7.37%
|
3.7%
|
4.39%
|
19.6%
|
15.5%
|
2.39%
|
7.5%
|
9.35%
|
Assets
1 |
7,237
|
10,156
|
2,817
|
13,745
|
10,128
|
15,280
|
20,981
|
31,117
|
Book Value Per Share
2 |
37.10
|
39.90
|
48.10
|
67.80
|
80.20
|
85.80
|
90.60
|
94.80
|
Cash Flow per Share
2 |
6.770
|
7.480
|
2.970
|
16.20
|
11.30
|
14.00
|
12.10
|
17.50
|
Capex
1 |
852
|
850
|
954
|
1,262
|
2,149
|
1,735
|
1,690
|
1,764
|
Capex / Sales
|
23.73%
|
27.18%
|
28.66%
|
17.24%
|
22.35%
|
28.78%
|
23.19%
|
20.53%
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
130.5
USD Average target price
154.3
USD Spread / Average Target +18.25% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.70% | 15.33B | | +17.59% | 66.6B | | +0.84% | 48.75B | | +17.11% | 41.45B | | +22.26% | 26.74B | | +11.45% | 19.55B | | +5.08% | 18.21B | | -21.31% | 16.02B | | +4.12% | 15.62B | | -20.79% | 13.62B |
Other Specialty Chemicals
|